i&i Biotech Fund I SCSp

Overview

i&i Biotech Fund I SCSp is a Luxembourg-based venture capital firm that invests in innovative European life sciences companies specializing in drug discoveries, medical devices, diagnostics, and digital health. Established in 2021 in cooperation with the European Investment Fund (EIF) and i&i Prague, the fund commenced operations with over €45 million under management. It plans to support more than 20 early-stage companies over the next five years, focusing on transformative Central European technology companies. The fund's investment strategy emphasizes early-stage companies in the life sciences sector, particularly those involved in drug discovery, medical devices, diagnostics, and digital health. With a team experienced in private equity, healthcare, and venture capital, i&i Biotech Fund offers strategic guidance, mentorship, and operational support to its portfolio companies. The fund also connects its investees with a network of investors and potential exit partners, facilitating partnerships and collaborations. i&i Biotech Fund I SCSp is part of an innovative ecosystem formed around the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (CAS). This affiliation allows the fund to be at the inception of transformative Central European technologies, supporting the transfer of new technologies from the laboratory to practice. The fund's close cooperation with i&i Prague, a biotech academic incubator, further strengthens its position in advancing innovative life sciences ventures in Europe.

Investment Focus

• Innovative European life sciences companies specializing in drug discoveries, medical devices, diagnostics, and digital health

Portfolio Companies